Back to Search Start Over

Aerosol Inhalation Delivery of Ceftriaxone in Mice: Generation Procedure, Pharmacokinetics, and Therapeutic Outcome.

Authors :
Valiulin SV
Onischuk AA
Baklanov AM
An'kov SV
Dubtsov SN
Alekseev AA
Shkil NN
Nefedova EV
Plokhotnichenko ME
Tolstikova TG
Dolgov AM
Dultseva GG
Source :
Antibiotics (Basel, Switzerland) [Antibiotics (Basel)] 2022 Sep 25; Vol. 11 (10). Date of Electronic Publication: 2022 Sep 25.
Publication Year :
2022

Abstract

Aerosol inhalation delivery of ceftriaxone in mice was investigated. An ultrasonic nebulizer within the ranges of mean particle diameter 0.5-1.5 μm and mass concentration 0.01-0.6 μg/cm <superscript>3</superscript> was used in inhalation experiments. Pharmacokinetic measurements were carried out using a nose-only chamber. Ceftriaxone concentration in blood serum and its mass in the lungs of mice were measured as a function of time using high-performance liquid chromatography. The body-delivered dose was within the range 3-5 mg/kg. The antibacterial effect of aerosolized ceftriaxone was investigated for mice infected with Klebsiella pneumoniae 82 and Staphylococcus aureus ATCC 25 953. The survival rate for infected mice after the treatment with ceftriaxone aerosol revealed the high antibacterial efficiency of this kind of treatment.

Details

Language :
English
ISSN :
2079-6382
Volume :
11
Issue :
10
Database :
MEDLINE
Journal :
Antibiotics (Basel, Switzerland)
Publication Type :
Academic Journal
Accession number :
36289963
Full Text :
https://doi.org/10.3390/antibiotics11101305